Naiera Mohamed | Medical Biotechnology | Best Researcher Award

Posted on by sciencefather

Assist Prof Dr. Naiera Mohamed | Medical Biotechnology | Best Researcher Award 

Assist Prof Dr. Naiera Mohamed, National Research Centre, Egypt

Orcid Profile

Educational Details

Assist. Prof. Dr. Naiera Mohamed holds a Ph.D. in Microbiology, awarded in 2016 from the Faculty of Science at Ain Shams University, Egypt, where her thesis focused on microbiological studies and the evaluation of antiviral activity from bacterial extracts. She also earned an M.Sc. in Microbiology in 2011 from the same institution, with research centered on the microbiological and biochemical studies related to calcium lactobionate production by certain bacteria. Additionally, she holds a Diploma in Bioinformatics (2019-2020) from Nile University, Egypt, and a Diploma in Molecular Biology (2018) from the Department of Biochemistry, Faculty of Science, Ain Shams University. Her foundational education includes a Bachelor of Science degree (2007) in Chemistry and Microbiology from Ain Shams University, where she graduated with a grade of Very Good.

Professional Experience

Assist. Prof. Dr. Naiera Mohamed is an accomplished academic and researcher currently serving as an Associate Professor in the Microbial Biotechnology department at the National Research Centre, Egypt, since June 2024. Her extensive career at the National Research Centre began in 2008, where she has held various roles, progressing from M.Sc. student to Assistant Researcher (2015-2017), Researcher (2017-2024), and now Associate Professor. She has been actively involved in groundbreaking research within the fields of microbiology and medical biotechnology, focusing on antimicrobial and antiviral activities, as well as innovative biotechnological applications in medicine.

Research Interest

Dr. Mohamed’s research spans microbiology, medical biotechnology, antiviral and antimicrobial drug development, vaccine design, and the production of bioprotective compounds using plant cell cultures. Her work primarily focuses on viral diseases, such as Hepatitis C, and biotechnological applications in the medical field, including antifungal agents and hepatoprotective compounds.

Research and Innovations

2023-2025: Member of a project repurposing antiviral drugs as novel anticancer agents by targeting structural and functional similarities between viral proteins and cancer, funded by the National Research Centre.

2019-2021: Part of a team developing a novel enzyme immunoassay for detecting HCV antibodies related to active viremia, funded by the National Research Centre.

2019-2023: Member of a grant focused on designing and developing a prophylactic virus-like particles-based vaccine against Hepatitis C Virus (HCV), funded by the STDF.

2019-2021: Involved in biotechnology-based research enhancing hepatoprotective compound production from Cumin and Anise plants for combatting hepatitis C-induced liver injury, funded by the National Research Centre.

2022: Collaborated with Chapman University’s School of Pharmacy to develop peptides with antifungal activity, funded by USAID.

Top Notable Publications

Naiera Mohamed. (2024). The Role of Peptides in Combatting HIV Infection: Applications and Insights. Preprints, DOI: 10.20944/preprints202409.0137.v1.

Naiera Mohamed, et al. (2024). Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia. Microbial Cell Factories, DOI: 10.1186/s12934-024-02297-1.

Naiera Mohamed, et al. (2023). Cyclic Peptides with Antifungal Properties Derived from Bacteria, Fungi, Plants, and Synthetic Sources. Pharmaceuticals, DOI: 10.3390/ph16060892.

Naiera Mohamed, et al. (2022). Polyphenol Content, Antioxidant, Cytotoxic, and Genotoxic Activities of Bombax ceiba Flowers in Liver Cancer Cells Huh7. Asian Pacific Journal of Cancer Prevention, DOI: 10.31557/APJCP.2022.23.4.1345.

Naiera Mohamed, et al. (2021). Circulating macrophage inflammatory protein-1β/IL-12p40 ratio predicts sofosbuvir-based treatment outcome in HCV- genotype 4 patients. Human Antibodies, DOI: 10.3233/HAB-211504.

Naiera Mohamed, et al. (2018). An extracted fraction of Pseudomonas oleovorans can inhibit viral entry and RNA replication of hepatitis C virus in cell culture. Collegium Antropologicum, EID: 2-s2.0-85069850106.

Naiera Mohamed, et al. (2016). Evaluating the antiviral activities of some bacteria against bovine viral diarrhea virus (BVDV). Current Trends in Biotechnology and Pharmacy, EID: 2-s2.0-84994350334.

Conclusion

Assist. Prof. Dr. Naiera Mohamed’s robust academic credentials, extensive professional experience, and significant contributions to biotechnology research position her as a strong contender for the Best Researcher Award. Her work in microbiology and medical biotechnology, particularly in antiviral and cancer research, has substantial global impact and demonstrates the innovation required for such prestigious recognition.